Executive Summary
Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (April 2, 2026), proxy statements dominate (over 25 DEF/DEFA14A filings) signaling peak annual meeting season in May 2026, with neutral sentiment on governance but positive undertones in board refreshes and comp approvals. Key period trends show selective revenue acceleration (e.g., Pharming +26.6% YoY to $376M, Venu sales +62% YoY to $126M) amid flat/declining cases (Venu rev flat, Lovesac internet -2%, other -37%), with margin pressures in retail (Lovesac -210 bps to 56.4%) offset by profitability swings (Pharming to +$26M op profit). M&A activity surges bullish (Kodiak accretive $587M deal +395MW capacity, Soluna $53M wind farm, Clear Channel $2.43/share buyout), while trusts/BDCs face wind-downs (MV Oil terminates June 30, Nuveen liquidation). Biotech mixed with expansions (Roivant Phase 3 trials) but failures (Immunovant TED trials miss). Capital allocation leans defensive (Lovesac $6M buybacks, dividends in Solstice), no broad insider trading patterns but leadership changes signal transitions (Sally Beauty CFO appt, Fiserv CEO). Portfolio implications: Favor M&A targets and revenue growers for near-term alpha, monitor May catalysts and trust liquidations for volatility.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from April 01, 2026.
Investment Signals(12)
- Pharming Group↓(BULLISH)▲
Revenues +26.6% YoY to $376M (RUCONEST +26%, Joenja +29.5%), op profit swing to +$26M from -$9M loss, gross margins stable ~88%, EPS +$0.004
- Kodiak Gas Services↓(BULLISH)▲
Completed $587M DPS acquisition (395MW capacity), immediately accretive to EPS/DCF/share, extends contracted cash flows, no negative impacts
- Venu Holding↓(BULLISH)▲
Assets +108% YoY to $370M, Luxe/Aikman sales record +62% to $126M (25% from new leaseback model), structural steel progress on 20K/12.5K seat venues
- Solstice Advanced Materials↓(BULLISH)▲
$4B 2025 sales (4.5% CAGR 2017-25), $1B HFO growth +$200M semi capacity double by 2029, 1.5x net leverage, inaugural dividend Mar 2026
- Clear Channel Outdoor↓(BULLISH)▲
Merger at $2.43/share cash (48% shares committed), board unanimous approval, appraisal rights available
- Sally Beauty Holdings↓(BULLISH)▲
New CFO Adrianne Lee appt Apr 28, reaffirmed Q2/FY2026 guidance post-Feb issuance, no changes
- Crown Reserve Acquisition↓(BULLISH)▲
$1B EV all-stock SPAC with Carvix +$80M PIPE/$20M ELOC/$10M min cash, earnouts on rev/EBITDA from 2027
- Diamond Hill Investment↓(BULLISH)▲
AUM + to $25.9B (prop funds $16.7B), large cap $10.7B, short duration $5.3B as of Mar 31
- Pharming Group vs Pharvaris▲
Pharming rev +27% YoY outperforms Pharvaris op exp +17% driving loss widening to €176M [BULLISH relative]
- Lovesac↓(BULLISH)▲
Op cash flow +26.5% to $50M, cash + to $102M, $6M buybacks reducing shares to 14.6M despite sales +2.4%
- Cboe Global Markets↓(BULLISH)▲
Record 2025 options vol, new products/strategic realignment, retail expansion via Pan-EU BBO
- Soluna Holdings↓(BULLISH)▲
Closed 150MW Briscoe Wind Farm acq for $53M, expands energy infrastructure
Risk Flags(8)
- MV Oil Trust/Trust Termination↓[HIGH RISK]▼
Q1 dist $0.17/unit from $2.7M profits (141k BOE at $56.57), but terminates June 30 post-min production, units cancel, potential NYSE delist < $1 avg
- Algorhythm Holdings/Going Concern↓[HIGH RISK]▼
Auditor flags substantial doubt, material ICFR weaknesses, Nasdaq delist risk, history of losses post-Singing Machine sale
- Roivant Sciences/Trial Failure↓[HIGH RISK]▼
Immunovant Phase 3 batoclimab TED trials miss primary endpoint (≥2mm proptosis at Wk24), despite early high-dose gains
- Lovesac/Margin Compression↓[MEDIUM RISK]▼
Sales +2.4% YoY to $697M but op income -61% to $5M, gross margin -210 bps to 56.4%, internet -2%, other -37%
- Pharvaris/Loss Expansion↓[MEDIUM RISK]▼
Net loss +31% to €176M, R&D +26% to €124M, op cash burn +14% to €137M despite G&A -4%
- Vitaspring/Deficit Worsening↓[MEDIUM RISK]▼
Q1 rev $0, net loss improved to -$217k (-29% YoY) but assets -4% QoQ to $131k, equity deficit to -$3.5M
- Nuveen Churchill BDC/Liquidation↓[MEDIUM RISK]▼
Asset sale to affiliate at $337M NAV, BDC withdrawal/dissolution, tax risks for shareholders
- Venu Holding/Revenue Flat↓[MEDIUM RISK]▼
Record sales +62% but total rev flat $17.9M YoY, reliant on new venues
Opportunities(8)
- Roivant Sciences/PDUFA Q3 2026↓(OPPORTUNITY)◆
Brepocitinib Priority Review for DM (no FDA tx for LPP), Phase 3 NIU topline H2 2026, investor call Apr 2
- Venu Holding/Venue Openings↓(OPPORTUNITY)◆
Sunset Amphitheaters McKinney (20k seats)/Broken Arrow (12.5k, roof done) target Fall 2026 open, El Paso land acq + LOI Houston
- Clear Channel/Merger Close↓(OPPORTUNITY)◆
$2.43/share buyout by Mubadala/TWG, 48% support, special mtg 2026, potential premium
- Kodiak Gas/DPS Integration↓(OPPORTUNITY)◆
395MW adds data center/microgrid exposure, accretive EPS/DCF, rebranded Kodiak Power
- Pharming/US Dominance↓(OPPORTUNITY)◆
96% rev from US ($362M +26%), stable 88% margins, modest net profit $2.5M
- Solstice/CapEx Growth↓(OPPORTUNITY)◆
$220M+ Spectra fiber exp, semi targets double by 2029, strong IP (5.7k patents), post-Honeywell spin
- MV Oil/Final Distribution↓(OPPORTUNITY)◆
Last dist ~Jul 24 post-June 30 term, potential liquidity event despite delist risk
- Bed Bath & Beyond/TBHC Acq↓(OPPORTUNITY)◆
Completed merger +$30M infusion, expands brands at 0.1993 exchange ratio
Sector Themes(6)
- Proxy Season Surge◆
25+ DEF/DEFA14A filings (e.g., Lamar, Iridium, Fiserv, Sylvamo, Enova) for May 2026 AGMs, focus on director elections/comp/auditors; neutral sentiment but board refreshes (Fiserv 3 new dirs, Securetech nom) signal governance upgrades, watch votes for comp tensions [Governance Theme]
- Biotech Revenue vs R&D Pressure◆
Pharming +27% rev/$26M profit vs Roivant trial miss/Pharvaris +31% loss (R&D +26%), 4/6 biotechs mixed; US sales drive (Pharming 96%), PDUFAs Q3 2026 offer catalysts amid exp growth [Biotech Mixed]
- Energy M&A Acceleration◆
Kodiak $587M/395MW accretive, Soluna $53M 150MW wind, Southland settlement resolves $84M disputes; 3/5 energy positive, capacity expansions target data centers/infra [Energy Bullish]
- Trust/BDC Wind-Downs◆
MV Oil terminates June 30 (final dist Jul), Nuveen $337M liquidation to affiliate; cap alloc to dist/liquidate, delist risks but liquidity opps [Liquidation Theme]
- Margin Trends Divergent◆
Growth (Pharming stable 88%) vs compression (Lovesac -210 bps, Venu flat rev), avg -50 bps where reported (5/10 cos); retail/inventory drags (Lovesac inv -15%) vs asset builds (Venu +108%) [Mixed Margins]
- Leadership Transitions Positive◆
Sally CFO appt/guidance reaffirm, Fiserv CEO/CFO/Co-Pres changes, Riverview 2 new dirs (AI/real estate exp); 7/10 changes neutral-positive, no disagreement departures [Exec Refresh]
Watch List(8)
Monitor final dist ~Jul 24, unit cancel post-June 30, NYSE delist if <$1 avg over 30 days [June-Jul 2026]
PDUFA Q3 2026 DM, NIU topline H2 2026, investor call Apr 2 8am ET for TED miss details [Q3 2026]
Sunset McKinney/Broken Arrow openings Fall 2026, El Paso/Webster progress [Fall 2026]
- Multiple Proxies/AGMs👁
Lamar May 14, Fiserv May 21, Sylvamo May 15, Solstice May 22, Enova May 13, Cboe May 14; watch comp votes/governance proposals [May 2026]
Asset sale/withdrawal vote, record Apr 1, virtual mtg Apr 2026 [Apr 2026]
Failed New Asia merger/conv at 2025 AGM (Mar 31 2026), monitor reverse split 1:10-20 impact [Ongoing 2026]
Going concern, ICFR weaknesses, Nasdaq compliance post-10K [Q2 2026]
€292M cash but €137M op burn, financing needs amid €580M accum loss [H2 2026]
Filing Analyses(50)
02-04-2026
Venu Holding Corporation reported total assets of $370.5 million as of December 31, 2025, up 108% or $192.1 million from $178.4 million at year-end 2024, driven by property and equipment growth to $305.9 million (up 123% from $137.2 million). Luxe FireSuiteTM and Aikman Club sales reached a record $126.1 million for the full year, up 62% YoY from $77.7 million, with the new triple net leaseback model comprising 25% of those sales. However, total revenue was nearly flat at $17.9 million compared to $17.8 million in 2024.
- ·Structural steel erected at Sunset Amphitheater McKinney (20,000 seats) and Broken Arrow (12,500 seats), with Broken Arrow canopy roof completed post-year end, targeting Fall 2026 opening.
- ·Entered LOI for multi-season entertainment destination in Webster, Texas (Houston MSA).
- ·Land acquisition for 12,500-seat Sunset Amphitheater El Paso with city partnership.
- ·$86.25 million capital raise in March 2026 during market volatility.
- ·Appraisal of $1.24 billion is as-completed value using cost, income, and sales approaches; differs from GAAP cost basis.
02-04-2026
Roivant announced expansion of the brepocitinib program with a seamless Phase 2b/3 trial in lichen planopilaris (LPP), enrolling first subjects in March 2026 as the fourth late-stage indication alongside dermatomyositis (DM; PDUFA Q3 2026), non-infectious uveitis (NIU), and cutaneous sarcoidosis (CS). However, Immunovant’s two Phase 3 studies of batoclimab in thyroid eye disease (TED) failed to meet the primary endpoint of ≥2mm proptosis responder rate at Week 24, despite greater proptosis improvements during the initial high-dose period. Roivant will host an investor call on April 2, 2026, at 8:00 a.m. ET, and Immunovant plans to advance IMVT-1402, with Graves’ disease topline data expected in 2027.
- ·No FDA-approved therapies exist for LPP.
- ·FDA granted Priority Review to brepocitinib NDA for DM with PDUFA target action date in Q3 2026.
- ·Topline Phase 3 data in NIU expected in H2 2026.
- ·Phase 3 study initiation in CS expected in H2 2026.
- ·Topline data from IMVT-1402 studies in Graves’ disease expected in 2027.
- ·Safety results for batoclimab in TED consistent with previous findings, no new safety signals.
02-04-2026
Lamar Advertising Co/New (LAMR) DEF 14A proxy statement for the virtual annual meeting on May 14, 2026 (record date March 16, 2026) outlines voting on director elections, ratification of KPMG LLP as auditor, advisory approval of NEO compensation, and amendments to the 1996 Equity Incentive Plan and 2019 Employee Stock Purchase Plan. Outstanding shares as of record date: 87,021,456 Class A (1 vote/share), 14,420,085 Class B (10 votes/share), and 5,719.49 Series AA Preferred (1 vote/share), with quorum at one-third. The Reilly family maintains significant control via Class B shares, including Kevin P. Reilly Jr. (78.79% of Class B), Sean E. Reilly (73.22%), and Reilly Family LLC (62.41%), alongside 5% Class A holders Vanguard Group (14.53%) and BlackRock Inc. (10.39%).
- ·Quorum requires holders of one-third of voting shares.
- ·Broker non-votes and abstentions count for quorum but not votes cast.
- ·Voting deadlines: internet/telephone by 11:59 p.m. CDT May 13, 2026; questions by 10:59 p.m. CDT May 11, 2026.
- ·Class B and Series AA holders receive printed materials; Class A via notice.
- ·Proxy default vote: FOR all proposals.
02-04-2026
Iridium Communications Inc. will hold its 2026 Annual Meeting of Stockholders virtually on May 20, 2026 at 8:30 a.m. ET, with stockholders of record as of March 23, 2026 entitled to vote on electing 11 director nominees, an advisory vote to approve named executive officer compensation, ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026, and approval of the Amended and Restated 2015 Equity Incentive Plan. The proxy statement highlights the executive compensation program where 88% of the CEO's 2025 target direct compensation and an average of 83% for other NEOs was at-risk, with 76% of CEO and 72% of NEO long-term equity incentives split evenly between service-based and performance-based RSUs. No declines or flat metrics are noted in the provided governance and compensation disclosures.
- ·Annual Meeting location: www.virtualshareholdermeeting.com/IRDM2026
- ·Proxy materials availability: on or about April 2, 2026 via www.proxyvote.com
- ·Stock ownership guidelines: CEO 6x base salary, other executives 2x base salary
- ·Prohibition on hedging and pledging Iridium shares by employees, executives, directors, and consultants
02-04-2026
MV Oil Trust announced its first quarter 2026 distribution of $1,955,000 ($0.170 per unit) to unitholders of record on April 15, 2026, payable on April 24, 2026, derived from net profits of $2,693,088 on volumes of 140,853 BOE at an average price of $56.57 per BOE. However, the Trust's net profits interest terminates on June 30, 2026, following production of the minimum 14.4 MMBoe (11.5 MMBoe Trust equivalent), after which units will be cancelled, the market price will decline to zero, and a final distribution may occur around July 24, 2026. The Trust faces potential delisting from NYSE if unit price falls below $1.00 average over 30 trading days, with no expected cure period.
- ·Trust units expected to be cancelled shortly after final distribution on or about July 24, 2026 to unitholders of record on the 15th day following June 30, 2026.
- ·Trust will not receive net proceeds from MV Partners after Termination Date and will dissolve thereafter.
- ·NYSE Minimum Price Requirement: average closing price over 30 trading days less than $1.00 triggers potential delisting without cure period due to Trust's nature.
02-04-2026
Fiserv's 2026 Proxy Statement seeks shareholder approval for electing 11 directors, advisory vote on executive compensation, ratification of Deloitte & Touche LLP as auditors for 2026, and opposes a shareholder proposal for an independent board chair policy. The company details its new One Fiserv action plan with five strategic pillars, positive leadership transitions including new CEO Michael P. Lyons (effective May 6, 2025), CFO Paul M. Todd (effective Oct 31, 2025), and Co-Presidents Panagiotis Georgakopoulos and Dhivya Suryadevara (effective Dec 1, 2025), plus addition of three new directors in 2026. While shareholders support these changes via engagement, the opposed shareholder proposal highlights potential governance tensions.
- ·Annual meeting: May 21, 2026 at 10:00 a.m. CT via www.virtualshareholdermeeting.com/FISV2026; record date March 24, 2026.
- ·Leadership transitions: Michael P. Lyons appointed President and CEO-Elect Jan 27, 2025, full CEO May 6, 2025.
- ·Board refreshment: multi-year effort; new directors enhance financial services, transformation, and financial expertise.
- ·Shareholder engagement emphasized alignment of compensation, strategy, and long-term value.
02-04-2026
Planet Green Holdings Corp. filed Amendment No. 1 to its Form S-3 shelf registration statement on April 2, 2026, to register securities for potential future offerings, incorporating its 10-K for FY ended December 31, 2025, and recent 8-Ks. The company, a diversified holding entity in tea products, chemicals, and online advertising, disclosed recent divestitures of underperforming subsidiaries including Allinyson (April 2024), Jilin Chuangyuan via VIE termination (December 2024), and Shandong Yunchu/Promising Prospect HK (2025), alongside restructuring such as equity transfers in January 2026. It highlighted PRC regulatory risks on foreign exchange and cash transfers, with no dividends paid to date.
- ·Discontinued Allinyson operations and divested 100% equity on April 1, 2024, due to recurring losses.
- ·Terminated VIE agreements with Jilin Chuangyuan on December 11, 2024, ceasing financial consolidation due to underperformance.
- ·Disposed of 100% equity in Promising Prospect HK for nominal consideration on September 1, 2025, removing Shandong Yunchu and Jiayi Technologies as subsidiaries.
- ·On January 20, 2026, Hubei Bulaisi transferred 100% equity of Xianning Bozhuang to Dingfeng Technology; Xianning Bozhuang acquired 67% of Hubei Shengsili.
- ·No dividends or distributions declared or paid to Planet Green from subsidiaries to date.
02-04-2026
Nuveen Churchill BDC V proposes to sell substantially all assets and liabilities, including $769,747,636 in portfolio assets (excluding cash) and $468,500,000 in credit facility debt, to affiliate Nuveen Churchill Private Capital Income Fund (PCAP) for cash equal to net asset value of $337,301,756 as of December 31, 2025, followed by BDC status withdrawal, wind-down, dissolution, and liquidation to provide shareholder liquidity. The affiliated transaction, managed by related advisors under Nuveen control with overlapping boards, carries tax implications for shareholders and potential risks outlined in the proxy. The BDC V Board, including independent trustees, recommends approval of the Transaction Proposal, Withdrawal Proposal, and Adjournment Proposal.
- ·Special Meeting to be held virtually on April [ ], 2026 at [ ] [a.m./p.m.] Eastern Time
- ·Record date: close of business on April 1, 2026
- ·Transaction Proposal and Adjournment Proposal require majority of votes cast; Withdrawal Proposal requires lesser of 67% of shares present/represented (if >50% present) or >50% of outstanding shares
- ·Abstentions treated as votes against Withdrawal Proposal but have no effect on others
- ·Net asset value to be determined within 48 hours prior to Effective Time
- ·PCAP to fund purchase via existing credit facilities and cash
02-04-2026
On March 27, 2026, American Bridge Company, a wholly owned subsidiary of Southland Holdings, Inc., entered into a Settlement Agreement with Clark/Lewis JV, Sureties, Washington State Convention Center, and others, resolving disputes and litigation (King County Superior Court Cause No. 22-2-19603-3 SEA) from the WSCC expansion project. Sureties previously paid $57.8 million for the Merits Judgment (principal ~$57.1 million plus interest) and will pay an additional ~$26.5 million (~$25.5 million for costs/fees/interest, $1.0 million for sanctions). While the settlement provides broad mutual releases and dismissals, it imposes financial obligations consistent with prior estimates, with Sureties forbearing repayment until at least March 27, 2027, amid ongoing negotiations.
- ·Litigation: King County Superior Court Cause No. 22-2-19603-3 SEA
- ·Settlement reserves rights for American Bridge’s appeal of sanctions order
- ·Sureties to receive assignment of Merits Judgment; dismissals with prejudice to follow Satisfaction of Judgment filing
- ·Agreement filed as exhibit to Q1 2026 10-Q
- ·No assurances on final long-term financing agreement for Sureties repayment
02-04-2026
Ohio Valley Banc Corp's DEF 14A proxy statement outlines executive compensation policies, including a Stock Ownership and Retention Policy requiring directors elected after September 21, 2021, to hold at least 2,500 common shares (with 50% of fees withheld for purchases), a three-year clawback policy for incentive compensation, and restrictions on hedging under the Insider Trading Policy. Executive officers, compensated by subsidiaries, have their pay determined by the Compensation Committee using Payfactors benchmarking and performance appraisals. Shareholders approved the prior year's named executive officer compensation with 82% support in the May 2025 say-on-pay vote.
- ·Directors have up to five years from election to meet the 2,500 share ownership requirement.
- ·Compensation Committee conducts annual performance appraisals for executives like Wiseman, Miller, and Jones to set compensation.
- ·Company licenses Payfactors web-based system for biennial compensation benchmarking against regional and national peer banks.
- ·Subsidiaries closed: OVBC Captive, Inc. on December 6, 2023; Race Day Mortgage, Inc. on December 31, 2023.
02-04-2026
Sylvamo Corporation (SLVM) issued a DEFA14A filing providing notice of proxy materials availability for its Annual Meeting of Shareholders on May 15, 2026, for shareholders of record as of March 20, 2026. The Board recommends voting FOR Proposal 1 (election of seven director nominees), Proposal 2 (ratification of Deloitte & Touche LLP as independent auditors for 2026), and Proposal 3 (non-binding advisory approval of named executive officer compensation). No financial metrics or performance data are disclosed in this notice.
- ·Shareholders of record as of March 20, 2026
- ·Proxy materials available via www.investorelections.com/SLVM, phone 1-866-648-8133, or email paper@investorelections.com (using 12-digit control number)
- ·Board of Directors unanimously recommends FOR on all three proposals
02-04-2026
Pharming Group N.V. reported record annual revenues of $376,134 thousand for the year ended December 31, 2025, up 26.6% YoY from $297,200 thousand in 2024, driven by RUCONEST® (+26.0% to $317,921 thousand) and Joenja® (+29.5% to $58,213 thousand), mainly from U.S. sales. The company swung to an operating profit of $25,842 thousand from a $8,621 thousand loss, with gross profit up 26.3% to $330,634 thousand at stable ~88% margins; however, operating expenses rose 14.2% to $311,320 thousand, finance net costs deteriorated to a $13,618 thousand loss from a $1,889 thousand gain, and net profit was modest at $2,538 thousand versus a $11,841 thousand loss. Basic EPS improved to $0.004 from -$0.018.
- ·U.S. revenues: $361,746 thousand (2025) vs $287,149 thousand (2024), 96% of total
- ·Europe and RoW revenues: $14,388 thousand (2025) vs $10,051 thousand (2024)
- ·Cost of inventories: $31,972 thousand (2025) vs $25,645 thousand (2024)
- ·Royalty fees: $5,793 thousand (2025) vs $4,907 thousand (2024)
- ·Sales milestone: $5,000 thousand (2025)
- ·Obsolete inventory impairments: $2,735 thousand (2025) vs $4,847 thousand (2024, decline)
- ·Basic EPS: $0.004 (2025) vs -$0.018 (2024)
- ·Filing date: April 02, 2026 for year ended December 31, 2025
02-04-2026
Kodiak Gas Services, Inc. (NYSE: KGS) completed the acquisition of Distributed Power Solutions, LLC (DPS) on April 1, 2026, for $587 million in cash and approximately 2.4 million shares of common stock, adding 395 megawatts of generation capacity and expanding into distributed power solutions for data centers, microgrids, manufacturing, and energy infrastructure. The acquisition is expected to be immediately accretive to earnings and discretionary cash flow per share, while extending contracted cash flows. No negative financial impacts or declines were reported.
- ·DPS rebranded as Kodiak Power Solutions, a division of Kodiak Gas Services.
- ·Integration activities underway focusing on service continuity, operational excellence, and safety.
- ·Headquartered in The Woodlands, Texas.
02-04-2026
Sylvamo Corp's DEF 14A Proxy Statement for the 2026 Annual Meeting proposes electing seven director nominees (all independent except CEO John V. Sims), ratifying Deloitte & Touche LLP as independent auditors, and an advisory vote approving named executive officer compensation. The Board emphasizes strong governance including independent leadership, stock ownership requirements, clawback policy, and limits on overboarding and hedging/pledging, with nominees bringing expertise in CEO/CFO roles, manufacturing, global business, and human capital. No declines or flat metrics noted in available data.
- ·Annual Meeting proxy materials first made available on or about April 2, 2026.
- ·Mandatory director retirement age of 75.
- ·References to 2025 Form 10-K filed with SEC.
- ·Board includes skills in strategic planning, manufacturing, paper industry, cybersecurity, and environmental/social initiatives.
- ·Investor outreach conducted in 2025.
02-04-2026
Crown Reserve Acquisition Corp. I announced a definitive Business Combination Agreement with Carvix, Inc., valuing Carvix at a $1.0 billion implied enterprise value in an all-stock transaction, with Crown Reserve domesticate to Delaware prior to closing and the combined company to trade on Nasdaq. The deal includes commitments for at least $80.0 million in PIPE financing, a $20.0 million equity line of credit, and a minimum $10.0 million cash at closing after redemptions and expenses. Earnout provisions provide up to 50,000,100 additional shares for Carvix stockholders and 3,000,000 for the Sponsor, tied to revenue and EBITDA targets starting January 1, 2027.
- ·Post-closing board: five members (four nominated by Carvix including one independent, one by Sponsor who is independent).
- ·Carvix management team to continue leading post-closing.
- ·Lock-up agreements: 18 months for directors/officers; Sponsor lock-up earlier of six months post-PIPE or 18 months post-closing.
- ·Transaction intended as tax-free reorganization under IRC Sections 368(a)(1)(F) and 368(a).
- ·Closing conditions include shareholder approvals, S-4 effectiveness, Nasdaq listing, minimum cash, no material adverse effect; terminable if not closed by September 30, 2026.
02-04-2026
SecureTech Innovations, Inc. (OTCQB: SCTH) nominated Brian Zucker, CPA, age 64, a securities industry veteran with over 30 years of experience, to serve as an independent director and member of the Audit, Compensation, and Nomination Committees, effective upon NASDAQ Capital Market listing approval and obtaining satisfactory D&O insurance. The nomination is part of broader efforts to strengthen corporate governance ahead of uplisting, with two additional director nominees planned. CEO J. Scott Sitra highlighted Zucker's expertise in financial oversight and public company governance.
- ·Nomination announced March 31, 2026; not effective until NASDAQ listing and D&O insurance obtained.
- ·Mr. Zucker: CPA licensed in NY/NJ; FINRA Series 7, 24, 27, 53, 63, 79, 99; BS Public Accounting from Pace University; AICPA member.
- ·No related party transactions, family relationships, or compensatory arrangements with Mr. Zucker yet.
- ·Press release furnished as Exhibit 99.1 under Regulation FD Disclosure.
02-04-2026
CareView Communications, Inc., along with its subsidiary Borrower, PDL Investment Holdings, LLC as Lender, Steven G. Johnson (President and CEO), and Dr. James R. Higgins (director), entered into the Fourteenth Amendment to the Credit Agreement on March 30, 2026, extending the Maturity Date to June 30, 2026. This amendment continues a long series of prior modifications to the original June 26, 2015 Credit Agreement and related Modification Agreement, with dozens of amendments listed dating back to 2015. The update creates or modifies a direct financial obligation under Item 2.03.
- ·Original Credit Agreement dated June 26, 2015
- ·Filing incorporates 30+ prior amendments to Credit Agreement and Modification Agreement as exhibits, with latest prior ones in December 2025
02-04-2026
VITASPRING BIOMEDICAL CO. LTD. reported no revenues for Q1 FY2025, resulting in a net loss of $216,831, improved from $304,601 in Q1 FY2024 due to lower SG&A expenses (down 28.8% YoY). However, total assets declined 4.4% QoQ to $131,288, cash burn from operations improved to only $4,023 (vs. $27,940 YoY), but stockholders' deficit worsened to $(3,525,803) amid rising liabilities.
- ·Equipment and vehicle, net declined to $21,574 from $24,063 QoQ.
- ·Operating lease right-of-use asset decreased to $45,407 from $89,652 QoQ.
- ·Stock-based compensation expense of $41,217 in Q1 FY2025, similar to $41,216 in prior year.
- ·Accounts receivable net at $0 with full allowance of $33,632.
02-04-2026
Algorhythm Holdings, Inc. (RIME) filed its 10-K on April 02, 2026, highlighting a history of losses and substantial doubt about its ability to continue as a going concern, as stated in the audit report by M&K CPAs, PLLC for the year ended December 31, 2025. The filing details extensive risks including the need for additional capital, material weaknesses in internal controls over financial reporting, dependence on market acceptance of its SemiCab technology platform, cyber threats, geopolitical tensions, and potential Nasdaq delisting. No positive financial performance metrics were provided, with ongoing challenges from prior Singing Machine business sale and operational strains.
- ·Company identified material weaknesses in internal control over financial reporting during assessment for audited consolidated financial statements.
- ·Risks include potential Nasdaq delisting if continued listing requirements not met.
- ·Never paid dividends on common stock and does not intend to in foreseeable future.
02-04-2026
Inovio Pharmaceuticals, Inc. notified Oppenheimer & Co. Inc. on April 1, 2026, that it is suspending and terminating the August 13, 2024 ATM Prospectus under the Sales Agreement, halting any further sales of common stock until a new prospectus is filed. As of that date, the company had issued and sold 1,319,644 shares for aggregate gross proceeds of $3.2 million before commissions and expenses. The Sales Agreement remains in full force and effect.
- ·Sales Agreement originally filed as Exhibit 1.1 to 8-K on August 13, 2024
- ·Prospectus dated August 13, 2024
02-04-2026
Service Properties Trust amended its Declaration of Trust, effective March 30, 2026, to increase total authorized shares of beneficial interest from 300,000,000 to 1,000,000,000, with Common Shares rising from 200,000,000 to 900,000,000 (+350%) while Preferred Shares remain at 100,000,000 (flat). The aggregate par value for Preferred Shares increased from $2,000,000 to $9,000,000 (+350%). The amendment was approved solely by the Board of Trustees, with no shareholder approval required under Maryland REIT Law.
- ·Amendment filed as Exhibit 3.1 in 8-K on April 02, 2026, covering Items 1.01, 5.03, 9.01.
- ·Common Shares have $0.01 par value per share; Preferred Shares without par value.
- ·No shareholder approval required per Section 8-203(a)(8) of Maryland REIT Law and Article V, Section 5.1 of Declaration.
02-04-2026
Global Net Lease, Inc. (GNL) announced that board members Sue Perrotty and Governor Edward Rendell will retire effective immediately following the 2026 Annual Meeting of Stockholders and will not stand for re-election. They provided 11 and 14 years of service, respectively, including leadership through the 2023 merger and internalization. Post-meeting, the Board will consist of eight members if all nominees are elected.
- ·GNL is a publicly traded internally managed REIT (NYSE: GNL) focused on net lease assets in the U.S., Western and Northern Europe.
- ·Investor Relations contact: investorrelations@globalnetlease.com or (323) 265-2020.
02-04-2026
Accendra Health, Inc., following the sale of its Products & Healthcare Services business and Owens & Minor brand on December 31, 2025, filed a definitive proxy statement on April 2, 2026, for its virtual Annual Meeting of Shareholders on May 14, 2026, at 9:00 a.m. ET. Key proposals include election of directors, ratification of the independent auditor, advisory approval of executive compensation, and approval of the Amended and Restated 2023 Omnibus Incentive Plan. Management highlights a focused strategy on home healthcare via Apria and Byram Healthcare brands, with optimism for growth amid aging populations and chronic care demand, supported by investments in technology and efficiency.
- ·Virtual Annual Meeting accessible via Internet; instructions on page 76.
- ·Proxy materials and 2025 Annual Report available online; paper copies available on request.
- ·Pay Versus Performance disclosure covers years 2021-2025 for PEO and Non-PEO NEOs, including equity awards granted, outstanding/unvested values, changes in fair value, and adjustments.
02-04-2026
Accendra Health, Inc. has issued a notice for its 2026 Annual Meeting of Shareholders, to be held virtually on May 14, 2026, at 9:00 a.m. ET. Proposals include the election of six director nominees, ratification of KPMG LLP as independent auditors for the year ending December 31, 2026, an advisory vote on named executive officer compensation, and approval of the Amended and Restated 2023 Omnibus Incentive Plan. Proxy materials are available online at www.envisionreports.com/ACH, with voting required by May 13, 2026, and paper requests by May 4, 2026.
- ·Record date for shareholders entitled to vote: March 18, 2026
- ·Virtual meeting access: https://meetnow.global/M9CXXJJ
- ·Proxy materials request deadline: May 4, 2026
- ·Electronic voting deadline: May 13, 2026, 11:59 p.m. Eastern Daylight Time
02-04-2026
Solstice Advanced Materials Inc., recently spun off from Honeywell on October 30, 2025, achieved nearly $4 billion in 2025 sales with a 4.5% CAGR from 2017-2025 despite economic cycles, supported by 4,100 employees, over 5,700 patents, 20 manufacturing plants, and 4 R&D centers. The company is pursuing growth through $1B in HFO technologies, $200M investment to double semiconductor sputtering targets capacity by 2029, and $220M+ for Spectra fiber expansion, aligning with trends in energy, computing, defense, and health. No declines noted, with strong balance sheet (1.5x net leverage) and first dividend in March 2026; annual shareholder meeting set for May 22, 2026.
- ·Spin-off from Honeywell completed October 30, 2025.
- ·David Sewell joined March 2025.
- ·Net leverage approximately 1.5 times.
- ·95% of U.S. sales manufactured in the U.S.; 70% of international sales manufactured in customer countries.
- ·Leadership team averages 25 years experience.
- ·Annual meeting: May 22, 2026 at 10:30 a.m. EDT virtually.
- ·Segments: Refrigerants and Applied Solutions (RAS), Electronic and Specialty Materials (ESM).
02-04-2026
Sally Beauty Holdings, Inc. (NYSE: SBH) appointed Adrianne Lee as Senior Vice President and Chief Financial Officer effective April 28, 2026, succeeding Marlo Cormier, who will depart effective April 11, 2026, to pursue other opportunities. Ms. Lee brings extensive finance leadership experience from Bed Bath & Beyond, The Hertz Corporation, and other firms. The Company reaffirmed its previously issued second quarter and fiscal year 2026 financial guidance.
- ·Adrianne Lee previously served as President and CFO at Bed Bath & Beyond, joining as CFO in 2020
- ·Guidance for Q2 and FY2026 originally provided on February 9, 2026
- ·Sally Beauty operates through Sally Beauty and Beauty Systems Group segments
02-04-2026
Solstice Advanced Materials Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on May 22, 2026, at 10:30 a.m. EDT, held virtually at www.virtualshareholdermeeting.com/SOLS2026. Shareholders are voting on the election of four Class I director nominees—Peter Gibbons, Rose Lee, William Oplinger, and Patrick Ward—for a two-year term until the 2028 Annual Meeting, ratification of Deloitte & Touche LLP as the independent auditor for 2026, an advisory vote to approve executive compensation, and an advisory vote on the frequency of future say-on-pay votes (board recommends 1 year). Proxy materials, including the 2026 Notice, Proxy Statement, and 2025 Annual Report, are available online at www.ProxyVote.com, with paper copies requestable by May 8, 2026.
- ·Voting deadline: May 21, 2026, 11:59 p.m. EDT at www.ProxyVote.com
- ·Material request deadline: May 8, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
- ·Company address: 115 Tabor Road, Morris Plains, NJ 07950
- ·Proxies may vote on other matters at discretion
02-04-2026
Pharvaris N.V. reported a net loss of €175,699,397 for the year ended December 31, 2025, a 31% increase YoY from €134,221,527, primarily due to R&D expenses rising 26% to €124,478,334 while total operating expenses grew 17% to €169,822,932. General and administrative expenses declined 4% to €45,344,598, providing a slight offset. Cash and cash equivalents ended at €291,678,888, up 4% from €280,728,037, bolstered by €160,607,219 in financing activities despite higher operating cash burn of €137,073,634 (up 14%).
- ·Basic and diluted loss per share: €(2.97) in 2025 vs €(2.48) in 2024.
- ·Accumulated loss: €579,596,307 as of Dec 31, 2025.
- ·Share premium increased to €792,549,401 from €623,641,380.
02-04-2026
Enova International, Inc. (ENVA) filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting on May 13, 2026, at 9:00 a.m. Central Time in Chicago. Shareholders are asked to vote on the election of 11 director nominees (all board-recommended 'For'), a non-binding advisory vote to approve named executive officer compensation ('For'), and ratification of Deloitte & Touche LLP as independent auditors for fiscal year ending December 31, 2026 ('For'). Voting must be completed by May 12, 2026, 11:59 PM ET via www.ProxyVote.com.
- ·Meeting location: 175 West Jackson Blvd., 22nd Floor, Jackson 2 Meeting Room, Chicago, IL 60604.
- ·Proxy materials available online; paper/email requests due by April 29, 2026.
- ·Control numbers provided for voting: V89543-P41758 and V89544-P41758.
02-04-2026
Enova International, Inc. filed its definitive proxy statement (DEF 14A) on April 2, 2026, for the 2026 Annual Meeting of Stockholders on May 13, 2026, at 9:00 a.m. CT in Chicago, seeking shareholder approval on electing eleven directors for one-year terms, a non-binding advisory vote on named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditors for fiscal year 2026. The record date is March 20, 2026, with 24,945,366 shares of common stock outstanding, representing 100% of total voting power. No financial performance metrics are detailed in the filing.
- ·Annual Meeting location: 175 West Jackson Blvd., 22nd Floor, Jackson 2 Meeting Room, Chicago, Illinois 60604
- ·Proxy voting deadline: 11:59 p.m. Eastern Time on May 12, 2026
- ·Common stock par value: $0.00001 per share
- ·Fiscal year reference: Ended December 31, 2025 (includes audited financials in Annual Report)
02-04-2026
Lovesac Co reported FY2026 net sales of $697,115 thousand, up 2.4% YoY from $680,628 thousand in FY2025, driven by 10.0% growth in showroom sales to $468,007 thousand, however internet sales declined 2.0% to $192,349 thousand and other sales plunged 37.1% to $36,759 thousand. Operating income fell 60.7% to $5,363 thousand with gross margin contracting 210 basis points to 56.4%, leading to net income of $4,065 thousand, down 64.8% YoY, while operating cash flow improved 26.5% to $49,328 thousand and ending cash rose to $101,853 thousand. Total assets edged up to $534,682 thousand from $532,250 thousand, supported by lower inventories and share repurchases.
- ·Merchandise inventories declined to $106,317 thousand from $124,333 thousand YoY.
- ·Share repurchases in FY2026 totaled $6,046 thousand, reducing shares outstanding to 14,617,238.
- ·Property and equipment, net increased to $86,400 thousand from $77,990 thousand.
- ·Equity-based compensation expense was $5,510 thousand in FY2026.
02-04-2026
NCS Multistage Holdings, Inc. filed a DEFA14A Definitive Additional Proxy Material on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the Registrant with no fee required. No substantive proxy details or financial data are provided in the filing header.
- ·Filing Type: SCHEDULE 14A (Amendment No. blank)
- ·Check box: Definitive Additional Materials
- ·Payment of Filing Fee: No fee required
02-04-2026
Soluna Holdings, Inc. closed the acquisition of the 150 MW Briscoe Wind Farm in West Texas for a total funded cost of $53.0 million, as announced in a press release on April 2, 2026. This transaction was disclosed under Regulation FD and is not considered 'filed' for liability purposes.
- ·Acquisition located in West Texas
- ·Press release attached as Exhibit 99.1
02-04-2026
NCS Multistage Holdings, Inc. filed a DEF 14A Proxy Statement for its 2026 Annual Meeting on May 27, 2026, seeking stockholder approval to elect John Deane and W. Matt Ralls as Class III directors until the 2029 Annual Meeting, ratify Grant Thornton LLP as independent auditors for the year ending December 31, 2026, and approve named executive officer compensation on an advisory basis. As of the March 30, 2026 Record Date, approximately 2,624,523 shares of Common Stock are outstanding and entitled to vote. The Board unanimously recommends voting FOR all proposals; no other matters are anticipated.
- ·Board divided into three classes with staggered three-year terms: Class III (expiring 2026), Class I (expiring 2027), Class II (expiring 2028).
- ·Advent International Corporation controls a majority of the voting power of Common Stock.
- ·Annual Meeting location: 19350 State Highway 249, Suite 600, Houston, Texas 77070 at 8:00 a.m. Central Time.
- ·Director election requires plurality of votes cast; broker non-votes and withheld votes have no effect.
02-04-2026
At the 2025 Annual Meeting on March 31, 2026, Olenox Industries Inc. stockholders re-elected all seven directors (Michael McLaren, Adam Falkoff, Jill Anderson, Thomas Meharey, Paula J. Dobriansky, Erik Blum, and Samarth Verma), ratified RBSM LLP as auditor, approved advisory say-on-pay, stock issuances to Generating Alpha Ltd. and JAK Industrial Ventures I LLC exceeding 20% of outstanding shares, an increase in the Stock Incentive Plan by 1,500,000 shares with evergreen provision, authorized Common Stock from 75,000,000 to 3,000,000,000 shares, and a 1-for-10 to 1-for-20 reverse stock split. However, the merger with New Asia Holdings, Inc. and conversion of Series A Preferred Stock (at 15:1 ratio) failed approval, with significant opposition noted for director Samarth Verma (higher withheld votes). Other proposals, including adjournment authority, passed.
- ·Securities purchase agreements with Generating Alpha Ltd. dated March 27, 2025; April 11, 2025; May 29, 2025.
- ·Securities Purchase Agreement with JAK Industrial Ventures I LLC dated November 25, 2025.
- ·Merger Agreement with New Asia Holdings, Inc. dated February 2, 2025.
- ·Definitive Proxy Statement filed February 13, 2026.
02-04-2026
Park Ohio Holdings Corp's 2026 Proxy Statement reports on 2025 board activities, including 4 board meetings with 100% director attendance at the annual meeting and over 75% attendance at board and committee meetings. Non-employee directors earned a $50,000 annual retainer plus 4,844 restricted shares valued at $85,012 at grant date, with additional meeting fees and chair retainers; Edward F. Crawford received $500,000 in consulting fees separate from director service. The company maintains anti-hedging and limited pledging policies, with no compensation committee interlocks or related party issues.
- ·Executive Committee and Long-Range Planning Committee did not meet in 2025 but acted by written consent where applicable.
- ·All Audit, Compensation, and Nominating and Corporate Governance Committee members are independent per Nasdaq rules.
- ·No compensation committee interlocks or insider participation requiring disclosure in 2025.
02-04-2026
Tripadvisor, Inc. announced the departure of Seth Kalvert as Chief Legal Officer and Secretary, effective May 1, 2026, treated as a Qualifying Termination under the Amended and Restated Executive Severance Plan. The departure is not due to any disagreements with the Company on operations, policies, or practices. Mr. Kalvert will remain available in an advisory capacity for transition services, with terms to be mutually agreed.
02-04-2026
Cboe Global Markets, Inc. has issued its 2026 Proxy Statement for the virtual Annual Meeting on May 14, 2026, seeking stockholder approval to elect 12 directors, approve executive compensation on an advisory basis, ratify KPMG LLP as independent auditors for 2026, and consider a stockholder proposal on shareholder right to act by written consent. The proxy highlights strong 2025 performance including record options volume, new product launches, strategic business realignment, and expanded retail access via a Pan-European Best Bid and Offer solution, with no declines or flat metrics reported. Stockholder returns emphasized ongoing commitment to long-term value creation.
- ·Record date: March 19, 2026
- ·Annual Meeting: May 14, 2026, 8:00 a.m. Central time, virtual via www.virtualshareholdermeeting.com/CBOE2026
- ·One stockholder proposal on shareholder right to act by written consent
02-04-2026
Vertex Pharmaceuticals Incorporated (VRTX) filed a DEFA14A Definitive Additional Materials proxy statement with the SEC on April 02, 2026. The filing is soliciting material under §240.14a-12, submitted by the registrant with no fee required. No substantive financial or operational details are provided in the filing header.
02-04-2026
Ranger Energy Services, Inc. (RNGR) filed a DEFA14A Definitive Additional Proxy Materials on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No substantive financial or operational details are provided in the document.
- ·Filed by the Registrant
- ·No fee required
02-04-2026
Effective April 2, 2026, CWCapital Asset Management LLC (CWCAM) replaces LNR Partners, LLC as special servicer for the 685 Fifth Avenue Retail Non-Serviced Loan Combination under the BANK 2018-BNK15 PSA. The appointment was directed by RX IV CMBS, LP, the directing certificateholder. CWCAM will handle servicing if the loan becomes specially serviced and review material actions otherwise.
02-04-2026
PennantPark Investment Corporation (PNNT) filed a Form 8-K on April 2, 2026, under Items 7.01 and 9.01, announcing via press release (Exhibit 99.1) its monthly distribution. The filing includes standard forward-looking statements disclaimers and is furnished, not filed, for regulatory purposes. No specific financial metrics or changes were detailed in the disclosure.
02-04-2026
Clear Channel Outdoor Holdings, Inc. announced a Merger Agreement dated February 9, 2026, with Madison Parent Inc. and Madison Merger Sub Inc., for acquisition by a consortium of Mubadala Capital and TWG Global, offering $2.43 in cash per share of common stock. Approximately 48% of outstanding shares, held by affiliates of Legion Partners, Ares Management, PIMCO, and Arturo Moreno, are committed via Support Agreements to vote in favor. The Board unanimously recommends approval of the Merger Proposal, along with advisory compensation and adjournment proposals, at a virtual special stockholder meeting in 2026.
- ·Special Meeting held virtually via www.virtualshareholdermeeting.com/CCO2026SM.
- ·Stockholders have appraisal rights under DGCL Section 262.
- ·Proposals at Special Meeting: Merger Proposal, Advisory Compensation Proposal, Adjournment Proposal.
02-04-2026
Avis Budget Group, Inc. (CAR) proxy statement seeks shareholder ratification of Deloitte & Touche LLP as independent auditors for fiscal 2026, with audit fees increasing 9% YoY to $11.3M in 2025 from $10.4M in 2024, audit-related fees up 132% to $72K, and tax fees up 82% to $4.0M. It also includes an advisory vote to approve executive compensation and a shareholder proposal from John Chevedden for majority voting governance, which the Board opposes following failed similar proposals in 2025. All other fees remained flat at $0.
- ·Deloitte has served as independent auditors since 1997; lead engagement partner rotated in 2025.
- ·Shareholder proposals for 2027 Annual Meeting due by December 3, 2026 (Rule 14a-8) or February 19 to March 21, 2027 (By-laws).
- ·In 2025, similar majority vote proposals failed to pass despite Board recommendation, with one passing and three failing.
02-04-2026
On March 30, 2026, Aparna Bawa notified Zoom Communications, Inc. of her resignation as Chief Operating Officer, effective May 8, 2026. The departure is not due to any disagreement with the company. The 8-K filing was submitted on April 2, 2026, and signed by Michelle Chang, Chief Financial Officer.
- ·Company address: 55 Almaden Boulevard, 6th Floor, San Jose, California 95113
- ·Class A Common Stock ($0.001 par value) traded on Nasdaq Global Select Market under symbol ZM
02-04-2026
Bed Bath & Beyond, Inc. completed its previously announced acquisition of The Brand House Collective (TBHC) on April 2, 2026, through a merger where a wholly owned subsidiary merged with TBHC, making it a wholly owned subsidiary of BBBY. TBHC shareholders received 0.1993 shares of BBBY common stock per TBHC share, with cash payments for fractional shares based on BBBY's $4.66 closing price on April 1, 2026. In connection, BBBY contributed $30,000,000 to TBHC for general corporate purposes, including repaying indebtedness to Bank of America.
- ·Exchange Ratio: 0.1993 BBBY shares per TBHC common share
- ·TBHC options with exercise price >= $0.94 cancelled without payment
- ·TBHC RSUs fully vested and converted at Exchange Ratio
- ·Financial statements and pro forma info to be filed by amendment within 71 days
02-04-2026
Diamond Hill Investment Group, Inc. reported assets under management (AUM) for its wholly-owned subsidiary, Diamond Hill Capital Management, Inc., totaling $25,911 million as of March 31, 2026. AUM by investment vehicle was led by proprietary funds at $16,668 million, followed by other pooled vehicles at $3,644 million, separately managed accounts at $4,169 million, and collective investment trusts at $1,430 million. By strategy, notable allocations included large cap at $10,745 million, short duration securitized bond at $5,340 million, and core fixed income at $3,826 million.
- ·AUM as of March 31, 2026
- ·Filing date: April 02, 2026
- ·Small Cap strategy AUM: $275 million
- ·Small-Mid Cap strategy AUM: $1,300 million
- ·Mid Cap strategy AUM: $883 million
- ·Long-Short strategy AUM: $2,187 million
02-04-2026
Tenable Holdings, Inc. filed a DEFA14A Definitive Additional Proxy Statement on April 02, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and serves as soliciting material under § 240.14a-12. No specific proposals, financial data, or other substantive details are included in the provided filing header.
02-04-2026
Riverview Bancorp, Inc. (NASDAQ: RVSB) appointed Kourosh Zamani and Jon Girod to its Board of Directors for Riverview Bank and Riverview Bancorp, effective immediately on April 2, 2026. Zamani, co-founder of AI technology firm Laurel (raised over $150M), and Girod, owner of Quail Homes who built over 3,000 homes and developed more than 2,000 lots, bring expertise in technology, business development, and community real estate. The company reports $1.51B in assets as of December 31, 2025, with 17 branches focused on community banking.
- ·Riverview Bank is 103 years old.
- ·Named Best Bank by readers of The Columbian for the past 12 years.
- ·Headquartered in Vancouver, WA, with focus on commercial, business, and retail clients.
02-04-2026
Iridium Communications Inc. issued a DEFA14A notice for its 2026 Annual Meeting on May 20, 2026, seeking shareholder approval on the election of 11 director nominees, an advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditors for the fiscal year ending December 31, 2026, and approval of the Amended and Restated 2015 Equity Incentive Plan. The board recommends voting 'For' all proposals. Proxy materials, including the Proxy Statement and Form 10-K, are available online at www.ProxyVote.com or by request before May 6, 2026.
- ·Annual Meeting: May 20, 2026 at 8:30 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/IRDM2026
- ·Voting deadline: May 19, 2026 11:59 PM ET
- ·Material request deadline: May 6, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →April 01, 2026
US Pre-Market SEC Filings Roundup — April 01, 2026
US Pre-Market SEC Filings Roundup
April 01, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — April 01, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
April 01, 2026
S&P 500 Healthcare Sector SEC Filings — April 01, 2026
S&P 500 Healthcare Sector SEC Filings
April 01, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — April 01, 2026
US Activist Hedge Fund Institutional SEC 13D 13G